Register to receive a free U.S. Market Report Suite for Wound and Tissue Management report synopsis and brochure
According to a new series of reports on the U.S. market for wound and tissue management by iData Research (www.idataresearch.com), the largest segment of the U.S. wound and tissue management market is the wound closure segment, which represented roughly 25% of the total market and is expected to exceed $2.6 billion by 2022. This market includes wound closure devices, static compression therapy, dynamic compression therapy, advanced dressings, hemostats, tissue sealants, anti-adhesion products and negative wound pressure therapy (NPWT).
It is estimated that more than 1 million diabetic foot ulcers are treated, which costs around $10 to $15 billion in expenditures. An additional $7 to $10 billion is spent on treating venous leg ulcers, and patients that requiring amputations as a result of poor wound management. The cost of chronic wound care in the U.S. is estimated to be between $25 and $50 billion annually, mainly consisting of nursing time and hospital admittance costs.
“Increased prevalence of diabetes will continue to put a burden on wound treatment in the the U.S. healthcare system,” explains Dr. Kamran Zamanian, CEO of iData. “There will be plenty of demand for wound management devices resulting in the market experiencing consistent strong growth over time.”
The advanced wound dressing market segment exhibited the highest growth over the forecast period. Growth was driven by strong sales of foam dressings along with continued unit sales growth of antimicrobial and interactive dressings. Further growth will be facilitated by the introduction of new products that will be easier to use. However, changes to reimbursement specific to the skin substitute market will result in slowed growth.
Ethicon, Acelity and Covidien (Medtronic) together, have captured nearly 50% of market share in U.S. wound and tissue management market. Although Ethicon’s products are relatively expensive compared to other competitors, it’s vast and diverse product portfolio across wound closure and biosurgery markets allows it to bundle different products together in service agreements, in order to secure large GPO contracts. KCI (Kinetic Concepts Inc.) continues to lead the negative pressure wound therapy market but their revenue is significantly affected by the competitive bidding process, which allows smaller competitors to increase their market penetration through aggressive pricing strategies.
Additional competitors covered in the iData U.S. wound and tissue management market report include Medline, 3M, Baxter, ConvaTec, Smith & Nephew, Mölnlycke, MiMedx, Pfizer, Integra Lifesciences, BSN Medical, Organogenesis, C. R. Bard, ArjoHuntleigh, Sanofi Genzyme, Osiris, mediUSA, Medicines Company, SIGVARIS, CryoLife, Aesculap USA, Z-Medica, Bio Compression Systems, Acell, Hartmann, Juzo, Teleflex, Stryker, Vascular Solutions, Derma Sciences, Lympha Press, Tactile Medical, Andover Healthcare, Albahealth, MCS, Circulator Boot Corporation, Celox and Carolon among others.
For Further Information
More on the wound tissue market in the U.S. can be found in a series of reports published by iData Research entitled the U.S. Market Report Suite for Wound and Tissue Management. The suite covers reports on the following markets: Wound Closure, Static Compression Therapy, Dynamic Compression Therapy, Advanced Dressings, Moist Dressings, Antimicrobial Dressings, Interactive Dressings, Non-Adherent Contact Layers, Traditional Wound Dressings, Hemostats, Tissue Sealants, Anti-Adhesion, and Negative Pressure Wound Therapy.
The iData report series on wound and tissue management covers the U.S., Japan, India, China and 15 countries in Europe including Austria, Belgium, Denmark, Finland, France, Germany, Italy, Luxembourg, Netherlands, Norway, Portugal, Spain, Sweden, the United Kingdom, and Switzerland. Reports provide a comprehensive analysis including units sold, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment. To find out more about wound tissue management market data, register online or email us at [email protected] for a U.S. Market Report Suite for Wound and Tissue Management brochure and synopsis.
About iData Research
iData Research (www.idataresearch.com) is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: Operating Room Equipment, Surgical Microscopes, Robotics and Surgical Navigation, Laparoscopy, Urology, Gynecology, Vascular Access, Endoscopy, Interventional Cardiology, Cardiac Surgery, Cardiac Rhythm Management, Electrophysiology, Ultrasound, X-Ray Imaging, Diagnostic Imaging, Oncology, Spinal Implants and VCF, Spinal MIS, Orthopedic Soft Tissue Repair and Regeneration, Orthopedic Trauma, Large & Small Joints, Anesthesiology, Wound Management, Orthopedics, Ophthalmics, Dental Operatory Equipment and more.
About Procedure Tracker
Procedure number data is available from iData’s Procedure Tracker service, which allows subscribers to define and analyze procedure data segmented by state, region, hospital, surgery centre, and physician. A customizable dashboard sorts procedure data for further analysis and research.
About Reimbursement Tracker
iData Research’s Reimbursement Policy Tracker enables medical device, dental, pharmaceutical and healthcare professionals to receive real-time policy updates from hundreds of insurance companies and 60,000+ policies across all therapeutic areas in the United States.
Explore our careers page for our current available job opportunities. This is your chance to join a fun and dynamic team in the medical market research industry. Send your resume to [email protected] with the job title in the subject line, and feel free to tell us a little about yourself. We look forward to hearing from you.